2-(4-((3,4-Dichlorobenzyl)oxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 250mg

[4-(2-Chlorophenyl)-tetrahydro-2H-pyran-4-yl]methanamine hydrochloride, 100mg

Acetic acid, [2-[2-(2-aminoethoxy)ethoxy]ethoxy]-, 95%, 1g

4-Fluorobenzenesulfonamide, 97.0%, 500g

Fluoxetine hydrochloride, 98.0%, 25g

1-(3-Chlorophenyl)-5-trifluoromethyl-1H-pyrazole-4-carboxylic acid, 97.0%, 1g

3-(2,3-Dihydro-1h-indole-1-sulfonyl)benzoic acid, 95%, 5g

Recipiente de reacción con brida plana cilíndrico, graduado (2) Fondo plano, DN 100, 160 mm, Altura, 350 mm, 1 Pieza

6-Fluoro-2-iodopyridin-3-ol, 97%, 1g

2-Oxo-1,2,3,4-tetrahydroquinoline-7-carboxylic acid, 95.0%, 500mg

(2R,3R)-2-Methylazetidin-3-ol hydrochloride, 98%, 5g

(4-(2-Chlorophenyl)thiazol-2-yl)methanol, 97%, 1g

2-(pyridin-2-yl)-3,4-dihydropyrimidin-4-one, 95%, 250mg